You have 9 free searches left this month | for more free features.

infliximab

Showing 1 - 25 of 774

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Infliximab
  • (no location specified)
Oct 27, 2023

Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

Not yet recruiting
  • Crohn's Disease
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 5, 2023

Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

Not yet recruiting
  • Crohn Disease
  • +4 more
  • TDM-based infliximab intravenous therapy
  • Standard infliximab intravenous therapy
  • (no location specified)
Sep 26, 2023

Therapeutic Monitoring of Infliximab and Adalimumab

Recruiting
  • Inflammatory Bowel Diseases
  • Trieste, Italy
    IRCCS Burlo Garofolo
Sep 5, 2023

Crohn Disease Trial in Beijing (Infliximab)

Not yet recruiting
  • Crohn Disease
  • Infliximab
  • Beijing, China
    Beijing Children's Hospital, Capital Medical University
Jun 13, 2023

Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

Not yet recruiting
  • Crohn Disease
  • Infliximab
  • (no location specified)
Apr 3, 2023

IBD Trial in Paris (Biocollection)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biocollection
  • Paris, France
    Saint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

Recruiting
  • Inflammatory Bowel Diseases
  • Rheumatologic Disease
  • Milano, Italy
    Irccs Ospedale San Raffaele
Jan 30, 2023

Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Infliximab biosimilar
  • Lahore, Punjab, Pakistan
    Services Institute of Medical Sciences
Dec 22, 2022

Psoriasis Trial in Lahore (Remsima)

Completed
  • Psoriasis
  • Lahore, Punjab, Pakistan
    Ghurki Hospital
Sep 12, 2023

Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

Not yet recruiting
  • Colitis
  • Infliximab
  • +2 more
  • Aalborg, Denmark
  • +2 more
Jul 7, 2023

90K/Mac-2 BP asIndicator of Early Response to Infliximab Therapy

Not yet recruiting
  • IBD
  • 90K
  • (no location specified)
Jul 18, 2023

Medicine Called Infliximab[Infliximab Biosimilar 3] in People

Not yet recruiting
  • Arthritis, Rheumatoid
  • +3 more
    • (no location specified)
    Mar 31, 2023

    Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

    Recruiting
    • Inflammatory Disease
    • +2 more
    • Infliximab subcutaneous
    • Immunosuppressive Agents
    • Amsterdam, North Holland, Netherlands
      Amsterdam UMC AMC
    Sep 27, 2023

    Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

    Not yet recruiting
    • Depressive Disorder, Major
    • Inflammation
    • Infliximab
    • Placebo
    • (no location specified)
    Nov 21, 2023

    Sterile Corneal Melt Trial in Montreal (Topical Infliximab)

    Recruiting
    • Sterile Corneal Melt
    • Topical Infliximab
    • Montreal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Dec 12, 2022

    Crohn's Disease, Exclusive Enteral Nutrition, Infliximab Trial (Infliximab, Exclusive Enteral Nutrition)

    Withdrawn
    • Crohn's Disease
    • +3 more
    • Infliximab
    • Exclusive Enteral Nutrition
    • (no location specified)
    Aug 5, 2022

    Crohn Disease, Child, Only, Biologic; Inadequate Trial (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • +2 more
    • Infliximab
    • (no location specified)
    Sep 20, 2022

    A 24-month Real Life PErsistence Efficacy and Safety Study in

    Recruiting
    • Inflammatory Bowel Diseases
    • Subcutaneous infliximab CT-P13 Remsima®SC
    • Grenoble, France
      Nicolas Mathieu
    Aug 2, 2022

    Sarcoidosis Trial (STOP arm)

    Not yet recruiting
    • Sarcoidosis
    • STOP arm
    • (no location specified)
    Jan 16, 2023

    IBD Trial in Saint Louis (Infliximab)

    Active, not recruiting
    • Inflammatory Bowel Diseases
    • Infliximab
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 31, 2022

    Infliximab in the Treatment of Chinese Crohn's Disease

    Active, not recruiting
    • Crohn Disease
    • Infliximab
    • Guangzhou, China
    • +4 more
    Jan 31, 2023

    Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

    Completed
    • Acute Graft-versus-host Disease
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 11, 2023

      Medication Belief on Adherence to Infliximab in Crohn's Disease

      Completed
      • Inflammatory Bowel Diseases
        • Zhejiang, China
          2ndAffiliated Hospital, School of Medicine, Zhejiang University,
        Mar 8, 2023

        Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

        Withdrawn
        • Idiopathic Refractory Scleritis
        • (no location specified)
        Jul 18, 2022